Regenerative Medical Technology Group Inc.
RMTG
$0.0264
-$0.0126-32.31%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 70.43% | 36.07% | 38.00% | 20.97% | 57.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.43% | 36.07% | 38.00% | 20.97% | 57.50% |
| Cost of Revenue | 74.91% | 22.82% | 33.67% | 3.18% | 12.38% |
| Gross Profit | 68.48% | 42.39% | 40.07% | 30.62% | 91.07% |
| SG&A Expenses | 19.19% | 18.04% | 11.28% | 23.45% | 20.55% |
| Depreciation & Amortization | -28.86% | 30.60% | 72.93% | 80.78% | 102.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.53% | 20.36% | 21.26% | 21.94% | 23.43% |
| Operating Income | 118.90% | 38.89% | 29.86% | -25.35% | 28.97% |
| Income Before Tax | 43.31% | 51.21% | -66.26% | -81.46% | -76.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.31% | 51.21% | -66.26% | -81.46% | -76.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.31% | 50.89% | -68.14% | -83.71% | -78.21% |
| EBIT | 118.90% | 38.89% | 29.86% | -25.35% | 28.97% |
| EBITDA | 210.33% | 89.73% | 74.17% | 0.69% | 52.96% |
| EPS Basic | 43.58% | 51.14% | -66.36% | -80.83% | -74.01% |
| Normalized Basic EPS | 23.12% | -2.45% | -21.96% | -32.29% | -26.12% |
| EPS Diluted | 43.58% | 51.14% | -66.36% | -80.83% | -74.01% |
| Normalized Diluted EPS | 23.12% | -2.45% | -21.96% | -32.29% | -26.12% |
| Average Basic Shares Outstanding | 0.56% | 0.67% | 1.32% | 1.69% | 2.32% |
| Average Diluted Shares Outstanding | 0.56% | 0.67% | 1.32% | 1.69% | 2.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |